ST-segment elevation and diminution of prostate-specific antigen in a patient with coronary spasm and without...

Area of Science:

• Cardiology
• Oncology
• Biomarkers

Background:

• Acute coronary syndrome (ACS) diagnosis can be challenging, especially when no culprit lesion is identified.
• Coronary artery spasm is a recognized cause of ACS and a crucial differential diagnosis.
• Prostate-specific antigen (PSA) is primarily known as a prostate cancer marker, but its role in cardiovascular events is under investigation.

Observation:

• Preliminary observations suggest a correlation between PSA levels and coronary lesion severity during acute myocardial infarction (AMI).
• Elevated PSA during AMI is associated with more frequent and severe coronary lesions.
• Diminished PSA during AMI may indicate conditions like coronary spasm without significant stenosis.

Findings:

• This case report details an ST-segment elevation myocardial infarction (STEMI) patient with diminished PSA, confirmed coronary artery spasm, and no significant coronary stenoses.
• The findings support the hypothesis that PSA levels can provide insights into the underlying mechanisms of ACS.
• The study highlights the potential of PSA as a biomarker in the context of acute cardiac events.

Implications:

• Considering PSA levels in ACS patients may aid in identifying non-obstructive causes like coronary spasm.
• Further research into PSA dynamics during ACS could refine diagnostic strategies and risk stratification.
• This case broadens the understanding of PSA's role beyond prostate cancer, linking it to acute cardiovascular conditions.